2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of …
…, M Casula, L Badimon, MJ Chapman… - European heart …, 2020 - academic.oup.com
version of the Guidelines, which is freely available via the ESC and EAS websites and
hosted on their journals’ websites (EHJ and Atherosclerosis Journal). The National Cardiac …
hosted on their journals’ websites (EHJ and Atherosclerosis Journal). The National Cardiac …
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and …
…, S Agewall, E Alegria, MJ Chapman… - European heart …, 2011 - academic.oup.com
Surveys and registries are needed to verify that real-life daily practice is in keeping with
what is recommended in the guidelines, thus completing the loop between clinical research, …
what is recommended in the guidelines, thus completing the loop between clinical research, …
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the …
…, O Wiklund, JK Stock, MJ Chapman… - European heart …, 2017 - academic.oup.com
Aims To appraise the clinical and genetic evidence that low-density lipoproteins (LDLs)
cause atherosclerotic cardiovascular disease (ASCVD). Methods and results We assessed …
cause atherosclerotic cardiovascular disease (ASCVD). Methods and results We assessed …
[HTML][HTML] Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort …
…, R Williams, G Vernet, M Chapman… - The Lancet Infectious …, 2022 - thelancet.com
Background The SARS-CoV-2 delta (B.1.617.2) variant was first detected in England in March,
2021. It has since rapidly become the predominant lineage, owing to high transmissibility. …
2021. It has since rapidly become the predominant lineage, owing to high transmissibility. …
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus …
BG Nordestgaard, MJ Chapman… - European heart …, 2013 - academic.oup.com
Aims The first aim was to critically evaluate the extent to which familial hypercholesterolaemia
(FH) is underdiagnosed and undertreated. The second aim was to provide guidance for …
(FH) is underdiagnosed and undertreated. The second aim was to provide guidance for …
Morbidity at bone graft donor sites
EM Younger, MW Chapman - Journal of orthopaedic trauma, 1989 - journals.lww.com
A review of the medical records of 239 patients with 243 autogenous bone grafts was
undertaken to document the morbidity at the donor sites. The overall major complication rate was …
undertaken to document the morbidity at the donor sites. The overall major complication rate was …
Lipoprotein (a) as a cardiovascular risk factor: current status
BG Nordestgaard, MJ Chapman, K Ray… - European heart …, 2010 - academic.oup.com
Aims The aims of the study were, first, to critically evaluate lipoprotein(a) [Lp(a)] as a
cardiovascular risk factor and, second, to advise on screening for elevated plasma Lp(a), on …
cardiovascular risk factor and, second, to advise on screening for elevated plasma Lp(a), on …
Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society consensus panel statement on assessment, aetiology and …
…, W März, CB Newman, M John Chapman… - European heart …, 2015 - academic.oup.com
Statin-associated muscle symptoms (SAMS) are one of the principal reasons for statin non-adherence
and/or discontinuation, contributing to adverse cardiovascular outcomes. This …
and/or discontinuation, contributing to adverse cardiovascular outcomes. This …
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the …
…, O Wiklund, MJ Chapman, M Cuchel… - European heart …, 2014 - academic.oup.com
Aims Homozygous familial hypercholesterolaemia (HoFH) is a rare life-threatening condition
characterized by markedly elevated circulating levels of low-density lipoprotein cholesterol (…
characterized by markedly elevated circulating levels of low-density lipoprotein cholesterol (…
Development of concern for others.
…, M Radke-Yarrow, E Wagner, M Chapman - Developmental …, 1992 - psycnet.apa.org
Investigated the development of prosocial and reparative behaviors by examining children's
responses to distresses they caused and those they witnessed in others during the 2nd yr of …
responses to distresses they caused and those they witnessed in others during the 2nd yr of …